News Pharma Industry

TPG-backed AHH picks controlling stake in Asian Institute of Nephrology & Urology for Rs 600 crore


Asia Healthcare Holdings, a single specialty healthcare delivery platform backed by US private equity firm TPG Growth on Wednesday said it has acquired a majority stake in Asian Institute of Nephrology and Urology ( AINU ), by investing Rs 600 crore in the company through a mix of primary and secondary infusion.

AINU is India’s largest single specialty hospital network of urology and nephrology care with a presence in four cities.

Enhance Your Healthcare Expertise with High-Impact Courses

Offering College Course Website
IIM Kozhikode IIMK Healthcare Management & Analytics Programme Visit
Indian School of Business ISB Healthcare Management Visit

The acquisition marks AHH’s foray into the urology and nephrology segment. AHH focuses on single specialty, since its launch in 2017, it has acquired single specialty chains such as CTSI (oncology), Motherhood Hospitals (women and child health), and Nova IVF (infertility).

AINU was founded in 2013 by a team of leading urologists and nephrologists led by C Mallikarjuna and P C Reddy, since then it has become a pioneering hospital network in the Urology & Nephrology clinical specialty in the country.
The company currently operates seven hospitals across Hyderabad, Visakhapatnam, Siliguri and Chennai. The network has more than 500 beds, has treated more than 400,000 patients and completed over 50,000 procedures. AINU has taken a leadership position in the country in the area of robotic urology surgery having completed over 1,000 surgeries with the use of robotic technology. On the nephrology front more than 200,000 dialysis and 300 kidney transplants have been performed by the enterprise.“AINU not only adds a new speciality to the AHH platform but also strengthens our vision of scaling the single specialty healthcare delivery ecosystem in the country,” said Vishal Bali, executive chairman, Asia Healthcare Holdings. “India is amongst the top three nations globally that has the highest incidence urological disorders, the high incidence of diabetes and hypertension is also accelerating the prevalence chronic kidney disease,” Bali said.“Indians have a high incidence of kidney stones, and non-cancerous prostate enlargement issues . Increasingly we have observed a rise in the incidence of urological cancer in the last decade.
We believe AHH has the legacy and is the right partner for the next phase of growth of our enterprise said,” Dr C Mallikarjun, chief consultant urologist and MD of AINU.

“Around 10% of the Indian population suffers from chronic kidney disease and every year over one lakh cases of renal failure are reported which makes nephrology care a key focus area for patients in India,” said Dr P.C .Reddy, senior urologist and ED of AINU.

In 2022, India recorded approximately 1.89 crores nephrology and rology procedures and is projected to grow 8-9% annually over the next five years making it one of the fastest growing specialties in the country.

There are 6,000 qualified urologists and 3,500 nephrologists in India. Approximately 350 urologists and 250 nephrologists graduate each year in India and the rise of laparoscopic, endoscopic and robotic surgical options gives a compelling growth opportunity for AINU to scale across the metros and tier 2 cities in the country.


Source link